Search Within

David P Kelsen

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (27)
  3. Editorial (1)
Groups
  1. Center for Pancreatic Cancer Research (58)
  2. Department of Medicine (58)
  3. GSK Faculty (58)
  4. Gastrointestinal Oncology Service (58)
  5. Human Oncology and Pathogenesis Program (58)
  6. Solid Tumor Oncology Division (58)

More Groups

People
  1. Marinela Capanu (30)
  2. Nikolaus Schultz (28)
  3. Geoffrey Ku (25)
  4. Joanne Chou (25)
  5. Yelena Janjigian (25)
  6. Michael Berger (23)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (4)
  4. 2022 (4)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Clinical Cancer Research (6)
  3. Annals of Oncology (4)
  4. Cancer (2)
  5. Cancer Discovery (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Association for Cancer Research (10)
  3. Oxford University Press (7)
  4. Nature Publishing Group (5)
  5. Wiley Blackwell (3)
  6. Cell Press (2)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort
    Journal Article

    Keane, F.; O’Connor, C.; Moss, D.; Chou, J. F.; Perry, M. A.; Crowley, F.; Saxena, P.; Chan, A.; Schoenfeld, J. D.; Singhal, A.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer
    Journal Article

    Bojmar, L.; Zambirinis, C. P.; Hernandez, J. M.; Chakraborty, J.; Shaashua, L.; Kim, J.; Johnson, K. E.; Hanna, S.; Askan, G.; Burman, J.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
    Journal Article

    Lior, C.; Barki, D.; Halperin, C.; Iacobuzio-Donahue, C. A.; Kelsen, D.; Shouval, R. S.
    Cell Reports (2024)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Journal Article

    Chatila, W. K.; Walch, H.; Hechtman, J. F.; Moyer, S. M.; Sgambati, V.; Faleck, D. M.; Srivastava, A.; Tang, L.; Benhamida, J.; Ismailgeci, D.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade
    Meeting Abstract

    Park, W.; Keane, F.; Bandlamudi, C.; Donoghue, M.; de Lara, P. T.; Harding, J. J.; Khalil, D.; McKinnell, Z.; Sterpi, M.; Cao, W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save